ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (4): 96-104.doi: 10.6040/j.issn.1673-3770.0.2023.130
HOU Lingxiao1, ZHANG Changcui2, XU Anting1, FAN Xintai1, WANG Na1
CLC Number:
| [1] Wheatley LM, Togias A. Allergic rhinitis[J]. N Engl J Med, 2015, 372(5): 456-463. doi:10.1056/nejmcp1412282 [2] Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control[J]. Immunol Allergy Clin North Am, 2016, 36(2): 235-248. doi:10.1016/j.iac.2015.12.002 [3] Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis[J]. Nat Rev Dis Primers, 2020, 6: 95. doi:10.1038/s41572-020-00227-0 [4] Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: Allergic rhinitis - 2023[J]. Int Forum Allergy Rhinol, 2023, 13(4): 293-859. doi:10.1002/alr.23090 [5] Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis[J]. Allergy, 2021, 76(11): 3383-3389. doi:10.1111/all.15044 [6] Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis[J]. Allergy, 2022, 77(11): 3309-3319. doi:10.1111/all.15454 [7] 黄嘉莉, 杨淑荣. 变应性鼻炎中信号传导通路的研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 125-129. doi:10.6040/j.issn.1673-3770.0.2019.355 HUANG Jiali, YANG Shurong. Advances in research on related signaling pathways in allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 125-129. doi:10.6040/j.issn.1673-3770.0.2019.355 [8] Miura K, Inoue K, Ogura A, et al. Role of CD4+ T cells in allergic airway diseases: learning from murine models[J]. Int J Mol Sci, 2020, 21(20): 7480. doi:10.3390/ijms21207480 [9] Cosmi L, Maggi L, Santarlasci V, et al. T helper cells plasticity in inflammation[J]. Cytometry A, 2014, 85(1): 36-42. doi:10.1002/cyto.a.22348 [10] Seumois G, Ramírez-Suástegui C, Schmiedel BJ, et al. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma[J]. Sci Immunol, 2020, 5(48): eaba6087. doi:10.1126/sciimmunol.aba6087 [11] Jin P, Zhang H, Zhu X, et al. Bioinformatics analysis of mRNA profiles and identification of microRNA-mRNA network in CD4+ T cells in seasonal allergic rhinitis[J]. J Int Med Res, 2022, 50(8): 3000605221113918. doi: 10.1177/03000605221113918 [12] 姜涛. 季节性过敏性鼻炎外周血CD4+T细胞基因测序数据挖掘及生物信息学分析[D]. 济南: 山东大学, 2022. doi:10.27272/d.cnki.gshdu.2022.003602 JIANG Tao. Bioinformatic analysis of RNA sequencing in peripheral CD4+ T cells of seasonal allergic rhinitis[D]. Jinan: Shandong University, 2022. doi:10.27272/d.cnki.gshdu.2022.003602 [13] 于克娜, 孙凯月, 张杰, 等. 西妥昔单抗治疗头颈部鳞状细胞癌差异表达基因的生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 117-124. doi:10.6040/j.issn.1673-3770.0.2020.189 YU Kena, SUN Kaiyue, ZHANG Jie, et al. Analysis of differentially expressed genes during cetuximab treatment of head and neck squamous cell carcinoma using bioinformatics[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 117-124. doi:10.6040/j.issn.1673-3770.0.2020.189 [14] 李琳, 高正文, 崔楠, 等. 儿童慢性鼻窦炎基因表达谱的生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 171-180. doi:10.6040/j.issn.1673-3770.0.2021.556 LI Lin, GAO Zhengwen, CUI Nan, et al. Bioinformatics analysis of gene expression profile in pediatric patients with chronic rhinosinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 171-180. doi:10.6040/j.issn.1673-3770.0.2021.556 [15] 顾瑜蓉, 李华斌. 《中国变应性鼻炎诊断和治疗指南(2022年,修订版)》解读[J]. 中国眼耳鼻喉科杂志, 2022, 22(2): 209-211. doi:10.14166/j.issn.1671-2420.2022.02.023 GU Yurong, LI Huabin. Interpretation of Chinese guideline for diagnosis and treatment of allergic rhinitis(2022, revision)[J]. Chinese Journal of Ophthalmology and Otorhinolaryngology, 2022, 22(2): 209-211. doi:10.14166/j.issn.1671-2420.2022.02.023 [16] Chen L, Shi L, Ma Y, et al. Hub Genes Identification in a Murine Model of Allergic Rhinitis Based on Bioinformatics Analysis[J]. Front Genet, 2020, 11: 970. doi: 10.3389/fgene.2020.00970 [17] Yan ZF, Liu LL, Jiao LL, et al. Bioinformatics analysis and identification of underlying biomarkers potentially linking allergic rhinitis and asthma[J]. Med Sci Monit, 2020, 26: e924934. doi:10.12659/MSM.924934 [18] Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease[J]. Cold Spring Harb Perspect Biol, 2018, 10(1): a029314. doi:10.1101/cshperspect.a029314 [19] Nur Husna SM, Tan HT, Shukri NM, et al. Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: overview and pathogenic insights[J]. Front Immunol, 2021, 12: 663626. doi:10.3389/fimmu.2021.663626 [20] Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions[J]. J Clin Invest, 1999, 104(1): 123-133. doi:10.1172/JCI5844 [21] 段甦, 韩新玲, 李颖, 等. 过敏性鼻炎鼻黏膜上皮紧密连接表达的研究[J]. 中国耳鼻咽喉头颈外科, 2021, 28(5): 293-296. doi:10.16066/j.1672-7002.2021.05.008 DUAN Su, HAN Xinling, LI Ying, et al. Study on the expression of tight junction of nasal mucosa epithelium in allergic rhinitis[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2021, 28(5): 293-296. doi:10.16066/j.1672-7002.2021.05.008 [22] 黄朝平, 张建辉, 朱力, 等. 紧密连接蛋白Claudin-1与变应性鼻炎发病机制相关性初探[J]. 中国眼耳鼻喉科杂志, 2014, 14(5): 283-286. doi:10.14166/j.issn.1671-2420.2014.05.033 HUANG Chaoping, ZHANG Jianhui, ZHU Li, et al. Correlation of claudin-1 and nosogenesis in allergic rhinitis[J]. Chinese Journal of Ophthalmology and Otorhinolaryngology, 2014, 14(5): 283-286. doi:10.14166/j.issn.1671-2420.2014.05.033 [23] 黄朝平, 张建辉, 朱力, 等. 紧密连接蛋白Occludin与变应性鼻炎发病机制相关性探讨[J]. 中国耳鼻咽喉颅底外科杂志, 2014, 20(4): 305-309. doi:10.11798/j.issn.1007-1520.201404005 HUANG Chaoping, ZHANG Jianhui, ZHU Li, et al. Effect of occludin on the pathogenesis of allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology-skull Base Surgery, 2014, 20(4): 305-309. doi:10.11798/j.issn.1007-1520.201404005 [24] Song H, Wang YP, Shi CJ, et al. SH3KBP1 promotes glioblastoma tumorigenesis by activating EGFR signaling[J]. Front Oncol, 2020, 10: 583984. doi:10.3389/fonc.2020.583984 [25] Moss TJ, Qi Y, Xi L, et al. Comprehensive genomic characterization of upper tract urothelial carcinoma[J]. Eur Urol, 2017, 72(4): 641-649. doi:10.1016/j.eururo.2017.05.048 [26] Wang J, Zhang Y, Ma T, et al. Screening crucial lncRNAs and genes in osteoarthritis by integrated analysis[J]. Adv Rheumatol, 2023, 63(1): 7. doi: 10.1186/s42358-023-00288-1 [27] Lan F, Wang QQ, Zhang L. Gene transcriptome analysis of nasal epithelial cells in chronic rhinosinusitis with nasal polyps[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2021, 56(10): 1066-1072. doi:10.3760/cma.j.cn115330-20210422-00219 [28] Frittoli E, Matteoli G, Palamidessi A, et al. The signaling adaptor Eps8 is an essential actin capping protein for dendritic cell migration[J]. Immunity, 2011, 35(3): 388-399. doi:10.1016/j.immuni.2011.07.007 [29] 张梓卉, 王振东, 白光宇, 等. Sin3A蛋白调节细胞功能综述[J]. 生命科学, 2015, 27(7): 892-897. doi:10.13376/j.cbls/2015122 ZHANG Zihui, WANG Zhendong, BAI Guangyu, et al. Sin3A regulates cell functions[J]. Chinese Bulletin of Life Sciences, 2015, 27(7): 892-897. doi:10.13376/j.cbls/2015122 [30] Peng LY, Li BB, Deng KB, et al. microRNA-214-3p facilitates M2 macrophage polarization by targeting GSK3B[J]. Kaohsiung J Med Sci, 2022, 38(4): 347-356. doi:10.1002/kjm2.12487 [31] 孙立薇, 刘子钰, 沙骥超, 等. 季节性与常年性变应性鼻炎鼻黏膜上皮细胞基因表达生物信息学分析[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(4): 425-432. doi: 10.3760/cma.j.cn115330-20210630-00397 SUN Liwei, LIU Ziyu, SHA Jichao, et al. Bioinformatics analysis of nasal epithelial cell gene expression in seasonal and perennial allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2022, 57(4): 425-432. doi: 10.3760/cma.j.cn115330-20210630-00397 [32] Zhao L, Li YY, Li CW, et al. Increase of poorly proliferated p63+/Ki67+ basal cells forming multiple layers in the aberrant remodeled epithelium in nasal polyps[J]. Allergy, 2017, 72(6): 975-984. doi:10.1111/all.13074 |
| [1] | QI Wenwen, CHEN Luqiu, JIA Tao, CHEN Xuemei, ZHANG Jie, ZHANG Hao, JIN Peng, ZHANG Hu. Potential biomarkers and bioinformatics analysis of differentially expressed genes in recurrent laryngeal papilloma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 75-84. |
| [2] | ObjectiveThe aim of this study was to provide new perspectives and targets for the treatment of HNSCC by screening differentially expressed genes during cetuximab treatment of head and neck squamous cell carcinoma(HNSCC)using bioinformatics. MethodsThe chip dataset, GSE109756, was downloaded from the GEO database, and the online analysis tool, GEO2R, was used to screen differentially expressed genes in head and neck squamous cell carcinoma tissues treated with and without cetuximab. The DAVID 6.8 and STRING online software were used to analyze the function of the differentially expressed genes, their pathway enrichment, and their protein interactions. Cytoscape was used to visualize and analyze the protein interactions. The online analysis tool, X2K, was used to find the transcription factors, the kinases of differentially expressed genes, and their mutual regulatory relationship with the targeted genes. ResultsNinety-one differentially expressed genes, including 50 up-regulated and 41 down-regulated genes(P<0.05; | logFC | > 1), were found in head and neck squamous cell carcinoma tissues treated with and without cetuximab. The GO and KEGG pathway analyses suggested that these differentially expressed genes were mainly enriched with immunomodulation, extracellular matrix, and other processes. Through the construction of a protein-protein interaction network, we screened CD163, VSIG4, and 3 other core differentially expressed genes(P<0.05), which were up-regulated after cetuximab treatment. In addition, our analysis shows that transcription factors, including SUZ12, TP63, and ESR1, played a key role in cetuximab treatment(P<0.05)and MAPK14, CDK1, and MAPK1 were the most important kinases during the process(P<0.05). ConclusionCD163, VSIG4, and the aforementioned transcription factors and protein kinases may be involved in the biological processes that underlie cetuximab treatment of HNSCC. This study provides new perspectives to facilitate further understanding of the biological mechanism that underlies cetuximab treatment of HNSCC and the exploration of the effectiveness of HNSCC treatment.. Analysis of differentially expressed genes during cetuximab treatment of head and neck squamous cell carcinoma using bioinformaticsYU Kena1, SUN Kaiyue2, ZHANG Jie1, JIN Peng1 1. Department of Otorhinolaryngology & Head and Neck Surgery, The Second Hospital of Shandong University, Jinan 250033, Shandong, China; 2. Shandong Provincial Otorhinolaryngology Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250022, Shandong, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 117-124. |
|
||